Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy

Leukemia. 2012 Apr;26(4):839-41. doi: 10.1038/leu.2011.279. Epub 2011 Oct 11.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy*
  • Recurrence
  • Salvage Therapy*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Thalidomide
  • pomalidomide